Nebulized Hypertonic Saline in the Treatment of Viral Bronchiolitis in Infants

Objective To investigate the use of nebulized 3% hypertonic saline (HS) for treating viral bronchiolitis in moderately ill hospitalized infants by a prospective, randomized, double-blinded, controlled, multicenter trial. Study design A total of 96 infants (mean age, 4.7 months; range, 0.3 to 18 mont...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of pediatrics 2007-09, Vol.151 (3), p.266-270.e1
Hauptverfasser: Kuzik, Brian A., MD, MSc, FRCP(C), Al Qadhi, Samim A., MD, MBChB, Kent, Steven, BSc(med), MD, FRCP(C), Flavin, Michael P., MB, MRCP(UK), FRCP(C), Hopman, Wilma, MA, Hotte, Simon, MD, Gander, Sarah, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective To investigate the use of nebulized 3% hypertonic saline (HS) for treating viral bronchiolitis in moderately ill hospitalized infants by a prospective, randomized, double-blinded, controlled, multicenter trial. Study design A total of 96 infants (mean age, 4.7 months; range, 0.3 to 18 months) admitted to the hospital for treatment of viral bronchiolitis were recruited from 3 regional pediatric centers over 3 bronchiolitis seasons (December 2003 to May 2006). Patients were randomized to receive, in a double-blind fashion, repeated doses of nebulized 3% HS (treatment group) or 0.9% normal saline (NS; control group), in addition to routine therapy ordered by the attending physician. The principal outcome measure was hospital length of stay (LOS). Results On an intention-to-treat basis, the infants in the HS group had a clinically relevant 26% reduction in LOS to 2.6 ± 1.9 days, compared with 3.5 ± 2.9 days in the NS group ( P = .05). The treatment was well tolerated, with no adverse effects attributable to the use of HS. Conclusions The use of nebulized 3% HS is a safe, inexpensive, and effective treatment for infants hospitalized with moderately severe viral bronchiolitis.
ISSN:0022-3476
1097-6833
DOI:10.1016/j.jpeds.2007.04.010